Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) has released an update. ResMed Inc.’s CEO, Michael J. Farrell, has executed a series of stock transactions as part of a ...

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) has released an update. Michael J. Rider, ...

Shares of ResMed Inc. RMD rallied 1.40% to $248.54 Thursday, on what proved to be an all-around mixed trading session for the ...

Shares of ResMed Inc. RMD inched 0.87% higher to $245.74 Tuesday, on what proved to be an all-around positive trading session ...

ResMed specializes in designing and manufacturing devices and software solutions for sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Its commitment to ...

Air Voel Expands Product Line with the Latest ResMed CPAP Machines for Enhanced Sleep Therapy.Canada - November 8, 2024 — Air ...

The cutoff for ResMed's latest payout is fast approaching. The post Want the latest ResMed dividend? Here's what you need to ...

ResMed is taking a “smart devices” and Big Data approach to further entrench itself as one of the two leading players in the global obstructive sleep apnea, or OSA, market. With cloud ...

Donald Trump’s win and the Fed’s second rate cut this year have brought back the lure for dividend investing. Trump's ...

For the quarter ended September 2024, ResMed (RMD) reported revenue of $1.22 billion, up 11.1% over the same period last year. EPS came in at $2.20, compared to $1.64 in the year-ago quarter.